retatrutide update Retatrutide—A Game Changer in Obesity Pharmacotherapy Retatrutide update with cat 😻

Dividing $4,200 by 36 pounds leaves us with an average annual per-pound cost of $116.67

Despite some states offering limited coverage of GLP-1s to treat weight loss as far back as a decade ago, most states that currently provide coverage through taxpayer-funded Medicaid programs or state employee health plans have only opted to do so within the past five years

GLP-1-directed delivery of the NMDA receptor antagonist MK-801 affects neuroplasticity in the hypothalamus and brainstem

Compounded GLP-1 medications come with several safety concerns, such as inconsistent dosing that can lead to accidental overdoses, a higher risk of side effects, and possible contamination